SOPH Q3 2021 Earnings — SOPHiA GENETICS S.A. Revenue & Financial Results | Market Cap Arena

SOPHSOPHiA GENETICS S.A.

$305M

Q3 2021 Earnings

Healthcare Medical - Healthcare Information Services

Income Statement

Revenue

$10M+44.5% YoY

Gross Profit

$7M63.2% margin

Operating Income

-$21M-197.9% margin

Net Income

-$21M-205.1% margin

EPS (Diluted)

$-0.35

QoQ Revenue Growth

+1.8%

Cash Flow

Operating Cash Flow

-$16M

Free Cash Flow

-$18M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$335M

Total Liabilities

$45M

Stockholders' Equity

$290M

Cash & Equivalents

$210M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10M	$7M	+44.5%
Gross Profit	$7M	$4M	+53.4%
Operating Income	-$21M	-$9M	-117.4%
Net Income	-$21M	-$10M	-103.0%